Use of Toll-Like Receptor 3 Agonists Against Respiratory Viral Infections

Abstract

Respiratory RNA viruses are constantly evolving, thus requiring development of additional prophylactic and therapeutic strategies. Harnessing the innate immune system to non-specifically respond to viral infection has the advantage of being able to circumvent viral mutations that render the virus resistant to a particular therapeutic agent. Viruses are… (More)

Topics

  • Presentations referencing similar topics